(Date:5/16/2008)...ire/ -- As tropical storms,continue to batter the ...,Cyclone Nargis are vulnerable to diseases and oth...stance, as exposure to the foul weather and,malnut...., "The people living in these conditions urgentl... get back on their feet," said David Meltzer,seni...
(Date:5/16/2008)...of Children Still in Danger, NEW YORK, May 16 /PR...rtising Council today announced a partnership to d...service announcements (PSAs) filmed by A-List,cele...el Madden, David,Duchovny, Tea Leoni, and Paul Rud...yclone. The Ad Council is distributing the new tel...
(Date:5/16/2008)...ire-FirstCall/ -- Nationwide,Health Properties, In...David,M. Boitano to Senior Vice President and Seni... contribution to NHP over the last several years a...versification strategy,successes. Dave has been re...ents for NHP, leveraging his vast experience and r...
(Date:5/16/2008)...l/ -- CryoCor, Inc. (Nasdaq:,CRYO), a medical devi...hythmias, announced today that on May 8, 2008, two...omplaint in the Superior Court of the State,of Cal... each member of the,Board of Directors of CryoCor,...mplaint is styled Secondido, et al. v. CryoCor, In...
Breaking Medicine News(10 mins):Health News:Myanmar Cyclone Survivors Face New Challenges 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 3Health News:David M. Boitano Promoted to Senior Vice President 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 3Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 4...udy carried out by the Indian Council of Medical R... international male in mind is too big for the Ind...rs found that about 50% of the men had penises sh...would fall or slip off leading to a failure rate o...
...ealth ministers of Canada are now pressing for mor.../ Wait times refer to the time allotted in days b...ate of its scheduling. This can vary from 2 days f...ataract surgery. It is fixed based on urgency of t...
...killer disease is battled with drugs and radiation...the humble walking, can reduce the mortality of ca...public is pretty much aware of the benefits of exe...sease, obesity and diabetes but little is known ab...
...associated to obesity can be prevented by consumin...US Researchers//. Obese people are higher risk of ...l cancer, post-menopausal breast cancer and a type... Luigi Fontana, a medical professor and his team a...
Other Medicine News:(Date:5/16/2008)... MONTVALE, N.J., May 16 /PRNewswire-FirstCall/...today announced progress with several key developm...tment community. The Company,reported new clinical...strating the compound,s CNS activity in humans. In...the lead development candidate from its,5-HT6 anta...
(Date:5/16/2008)... Nektar,s Technology Enables First-Ever PEGylatio...strated Therapeutic Activity, SAN CARLOS, Calif.,...ics (Nasdaq: NKTR ) announced initial results tod...inotecan. The data shows significant,anti-tumor ac...he study,also demonstrates that Nektar,s small mol...
(Date:5/15/2008)... - Trial Results Confirm Efficacy for Population ...VILLE, Calif., May 16 /-,Ba...maceuticals, Inc.,(Nasdaq: ONXX ) today announced... improved overall survival by 47.3 percent (HR=0.6...region with advanced,hepatocellular carcinoma (HCC...
(Date:5/15/2008)... - Safety and Efficacy Clinical Data from Prostat... Cancers -, - Company to Hold Investor Event...AN FRANCISCO, Calif., May 15 /PRNewswire-FirstCall...), a biopharmaceutical company focused,on oncology...ta from three,clinical trials of picoplatin, in va...
Breaking Medicine Technology:Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 2Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 3Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5AAAAI 3A Early Day Care Attendance May Protect Infants From Later Developing Asthma From the Journal of Allergy and Clinical Immunology 3742 1AAAAI 3A Early Day Care Attendance May Protect Infants From Later Developing Asthma From the Journal of Allergy and Clinical Immunology 3742 2Jewish Hospital 26 St Marys Healthcare Select Perot Systems for Technology Services 3739 1Jewish Hospital 26 St Marys Healthcare Select Perot Systems for Technology Services 3739 2Jewish Hospital 26 St Marys Healthcare Select Perot Systems for Technology Services 3739 3ASGE Applauds News of Drop in Colorectal Cancer Deaths 3736 1ASGE Applauds News of Drop in Colorectal Cancer Deaths 3736 2ASGE Applauds News of Drop in Colorectal Cancer Deaths 3736 3PA Department of Public Welfare Reminds New Parents About Safe Haven Law 3733 1PA Department of Public Welfare Reminds New Parents About Safe Haven Law 3733 2...IRE)--Apr 16, 2007 - Antigenics Inc.,(NASDAQ: AGEN...data,from a Phase 1/2 investigator-sponsored trial...ncophage(R) (vitespen) in,recurrent, high-grade gl...sociation of Neurological Surgeons (AANS; abstract...conducted at the,Brain Tumor Research Center at th...
...S, 16 April 2007- Antisoma announces that,preclini...ed this,week at the Annual Meeting of the American...vastin-paclitaxel triple combination highly effect...evaluated a triple,combination of the Company,s va...ic Avastin and the chemotherapy drug paclitaxel. T...
Other Medicine Technology:Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 2Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 3Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 4Data supporting three Antisoma programmes presented at AACR 2Data supporting three Antisoma programmes presented at AACR 3Data supporting three Antisoma programmes presented at AACR 4...ing more efficiency for high volume laboratories, ...provides extended walk away time. This high-speed ...up to 1600 photometric test results per hour (up t...ts on-board. Consolidate with Olympus 122 test men...
...Fit truly is a one size fits all plug. Once insert...inute period. As it hydrates, Form Fit increases i...licular cavity to form a perfect fit. ,The Form...nds into a soft, pliable, gelatinous material when...
Fully automated immunochemiluminometric assay for the rapid intraoperative,measurement of Intact PTH 1-84 using human serum or EDTA plasma.
...ariLite dual wavelength (532 nm and 940 nm) laser ... This solid-state laser quickly and effectively tr...vulgaris. VariLite offers the clinical versatility...s deeper, larger vessels in a convenient, affordab...
Medicine Products: